99 related articles for article (PubMed ID: 1655216)
1. Serum immunoerythropoietin levels in patients with cancer receiving cisplatin-based chemotherapy.
Smith DH; Goldwasser E; Vokes EE
Cancer; 1991 Sep; 68(5):1101-5. PubMed ID: 1655216
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
[TBL] [Abstract][Full Text] [Related]
3. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
4. Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapy.
Canaparo R; Casale F; Muntoni E; Zara GP; Della Pepa C; Berno E; Pons N; Fornari G; Eandi M
Br J Clin Pharmacol; 2000 Aug; 50(2):146-53. PubMed ID: 10930966
[TBL] [Abstract][Full Text] [Related]
5. Serum erythropoietin levels in gynecologic cancer patients during cisplatin combination chemotherapy.
Hasegawa I; Tanaka K
Gynecol Oncol; 1992 Jul; 46(1):65-8. PubMed ID: 1634143
[TBL] [Abstract][Full Text] [Related]
6. Decreased erythropoietin response in patients with the anemia of cancer.
Miller CB; Jones RJ; Piantadosi S; Abeloff MD; Spivak JL
N Engl J Med; 1990 Jun; 322(24):1689-92. PubMed ID: 2342534
[TBL] [Abstract][Full Text] [Related]
7. Serum erythropoietin levels in ovarian cancer patients receiving chemotherapy.
Pedain C; Herrero J; Künzel W
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):224-30. PubMed ID: 11574136
[TBL] [Abstract][Full Text] [Related]
8. Serum erythropoietin level in anemic cancer patients.
Ozguroglu M; Arun B; Demir G; Demirelli F; Mandel NM; Buyukunal E; Serdengecti S; Berkarda B
Med Oncol; 2000 Feb; 17(1):29-34. PubMed ID: 10713657
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients.
Arslan M; Evrensel T; Kurt E; Demiray M; Ercan I; Kanat O; Ozkan A; Manavoglu O
Neoplasma; 2005; 52(1):43-5. PubMed ID: 15739025
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.
Mantovani G; Ghiani M; Curreli L; Maccio A; Massa D; Succu G; Lai P; Massa E; Mudu MC; Astara G
Oncol Rep; 1999; 6(2):421-6. PubMed ID: 10023014
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-associated anemia: an erythropoietin deficiency syndrome.
Wood PA; Hrushesky WJ
J Clin Invest; 1995 Apr; 95(4):1650-9. PubMed ID: 7706473
[TBL] [Abstract][Full Text] [Related]
12. Serum immunoreactive erythropoietin in HIV-infected patients.
Spivak JL; Barnes DC; Fuchs E; Quinn TC
JAMA; 1989 Jun; 261(21):3104-7. PubMed ID: 2716142
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.
Abels RI
Semin Oncol; 1992 Jun; 19(3 Suppl 8):29-35. PubMed ID: 1615337
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin response to post-liver transplantation anemia.
Vasilopoulos S; Hally R; Caro J; Martin P; Westerberg S; Moritz M; Jarrell B; Muñoz S
Liver Transpl; 2000 May; 6(3):349-55. PubMed ID: 10827238
[TBL] [Abstract][Full Text] [Related]
17. Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer.
Schmidinger M; Budinsky AC; Wenzel C; Piribauer M; Brix R; Kautzky M; Oder W; Locker GJ; Zielinski CC; Steger GG
Wien Klin Wochenschr; 2000 Jul; 112(14):617-23. PubMed ID: 11008323
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin in the treatment of the anaemia of cancer.
Abels RI
Acta Haematol; 1992; 87 Suppl 1():4-11. PubMed ID: 1574966
[TBL] [Abstract][Full Text] [Related]
19. Changes in levels of serum erythropoietin, serum iron and unsaturated iron binding capacity during chemotherapy for lung cancer.
Sawabe Y; Takiguchi Y; Kikuno K; Iseki T; Ito J; Iida S; Kuriyama T; Yonemitsu H
Jpn J Clin Oncol; 1998 Mar; 28(3):182-6. PubMed ID: 9614440
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia.
Miller CB; Platanias LC; Mills SR; Zahurak ML; Ratain MJ; Ettinger DS; Jones RJ
J Natl Cancer Inst; 1992 Jan; 84(2):98-103. PubMed ID: 1735886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
